L. Holterman

发表

Direct amplification and cloning of up to 5-kb lentivirus genomes from serum.

J. Heeney, L. Holterman, J. Mullins, 1996, BioTechniques.

Comparative Seroprevalence and Immunogenicity of Six Rare Serotype Recombinant Adenovirus Vaccine Vectors from Subgroups B and D

K. Mansfield, M. Havenga, A. Lemckert, 2007, Journal of Virology.

Novel replication-incompetent adenoviral B-group vectors: high vector stability and yield in PER.C6 cells.

M. Havenga, A. Lemckert, R. Vogels, 2006, The Journal of general virology.

Generation of a novel replication-incompetent adenoviral vector derived from human adenovirus type 49: manufacture on PER.C6 cells, tropism and immunogenicity.

B. Berkhout, P. Quax, M. Havenga, 2006, The Journal of general virology.

Adenovirus serotype 5 infects human dendritic cells via a coxsackievirus-adenovirus receptor-independent receptor pathway mediated by lactoferrin and DC-SIGN.

R. Koup, G. B. Karlsson Hedestam, M. Havenga, 2009, The Journal of general virology.

Differential Antigen Requirements for Protection against Systemic and Intranasal Vaccinia Virus Challenges in Mice

J. Héraud, D. Kaufman, M. Havenga, 2008, Journal of Virology.

Increased immunogenicity of recombinant Ad35-based malaria vaccine through formulation with aluminium phosphate adjuvant.

M. Havenga, K. Radošević, J. Goudsmit, 2007, Vaccine.

Impact of Recombinant Adenovirus Serotype 35 Priming versus Boosting of a Plasmodium falciparum Protein: Characterization of T- and B-Cell Responses to Liver-Stage Antigen 1

G. Weverling, M. Havenga, K. Radošević, 2008, Infection and Immunity.

Novel Replication-Incompetent Vector Derived from Adenovirus Type 11 (Ad11) for Vaccination and Gene Therapy: Low Seroprevalence and Non-Cross-Reactivity with Ad5

B. Berkhout, P. Quax, M. Havenga, 2004, Journal of Virology.

Lymphoproliferative disorders developing after transplantation and their relation to simian T‐cell leukemia virus infection

J. Heeney, H. Stevens, L. Holterman, 1992 .

Lymphoproliferative disorders developing after transplantation and their relation to simian T-cell leukemia virus infection.

J. Heeney, H. Stevens, L. Holterman, 1992, Transplant international : official journal of the European Society for Organ Transplantation.

Age Dependence of Adenovirus-Specific Neutralizing Antibody Titers in Individuals from Sub-Saharan Africa

P. Jeena, G. Weverling, M. Havenga, 2006, Journal of Clinical Microbiology.

Vaccine protection and reduced virus load from heterologous macaque-propagated SIV challenge.

J. Heeney, H. Niphuis, S. Norley, 1994, AIDS research and human retroviruses.

Expression and immunogenicity of the Plasmodium falciparum circumsporozoite protein: the role of GPI signal sequence.

M. Havenga, K. Radošević, J. Goudsmit, 2007, Vaccine.

Hexon-chimaeric adenovirus serotype 5 vectors circumvent pre-existing anti-vector immunity

K. Mansfield, M. Lifton, M. Havenga, 2006, Nature.

Immunogenicity and Protection of a Recombinant Human Adenovirus Serotype 35-Based Malaria Vaccine against Plasmodium yoelii in Mice

B. Berkhout, M. Tsuji, M. Havenga, 2006, Infection and Immunity.

Immunogenicity of Heterologous Prime-Boost Regimens Involving Recombinant Adenovirus Serotype 11 (Ad11) and Ad35 Vaccine Vectors in the Presence of Anti-Ad5 Immunity

M. Lifton, M. Havenga, A. Lemckert, 2005, Journal of Virology.

Serum‐free transient protein production system based on adenoviral vector and PER.C6 technology: High yield and preserved bioactivity†

G. Hateboer, M. Havenga, R. Vogels, 2007, Biotechnology and bioengineering.

The pathogenesis of AIDS: lessons from the SIV-Macaque model

L. Holterman, 1999 .

Myeloid and Plasmacytoid Dendritic Cells Are Susceptible to Recombinant Adenovirus Vectors and Stimulate Polyfunctional Memory T Cell Responses

R. Koup, M. Havenga, J. Goudsmit, 2007, The Journal of Immunology.

High-level expression from two independent expression cassettes in replication-incompetent adenovirus type 35 vector.

M. Havenga, R. Vogels, K. Radošević, 2007, The Journal of general virology.

Primate Lentiviruses and AIDS Research

J. Heeney, B. Rosenwirth, E. Verschoor, 1998 .

The rate of progression to AIDS is independent of virus dose in simian immunodeficiency virus-infected macaques.

J. Heeney, H. Niphuis, L. Holterman, 2000, The Journal of general virology.

Specific passage of simian immunodeficiency virus from end-stage disease results in accelerated progression to AIDS in rhesus macaques.

J. Heeney, H. Niphuis, J. Goudsmit, 1999, The Journal of general virology.

Molecular cloning of the gene for the E1 alpha subunit of the pyruvate dehydrogenase complex from Saccharomyces cerevisiae.

L. Holterman, I. Dekker, T. Wenzel, 1990, European journal of biochemistry.

Characteristics of a Pathogenic Molecular Clone of an End-Stage Serum-Derived Variant of Simian Immunodeficiency Virus (SIVF359)

G. Learn, J. Mullins, J. Heeney, 2001, Journal of Virology.

A strategy for cloning infectious molecular clones of retroviruses from serum or plasma.

J. Heeney, L. Holterman, J. Mullins, 2000, Journal of virological methods.

Comparative characterization of hexose transporters of Plasmodium knowlesi, Plasmodium yoelii and Toxoplasma gondii highlights functional differences within the apicomplexan family.

A. Thomas, S. Krishna, T. Joët, 2002, The Biochemical journal.

Serum‐free transient protein production system based on adenoviral vector and PER.C6 technology: High yield and preserved bioactivity†

Martin H. Koldijk, R. Vogels, L. Holterman, 2007, Biotechnology and bioengineering.